Polypills with or without aspirin for primary prevention of cardiovascular disease

Polypills with or without aspirin for primary prevention of cardiovascular disease

書誌詳細
主要な著者:	Mant, J, McManus, R
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2021

類似資料

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
著者:: Virdee, S, 等
出版事項: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
著者:: Jowett, S, 等
出版事項: (2017)

Polypill for cardiovascular disease prevention.
著者:: Dalton, A
出版事項: (2013)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
著者:: Sue Jowett, 等
出版事項: (2017-01-01)

The Concept of the Polypill in the Prevention of Cardiovascular Disease
著者:: Brandon Wiley, 等
出版事項: (2014-04-01)

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
著者:: J. Masjuan, 等
出版事項: (2021-01-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
著者:: Omneya A. Kandil, 等
出版事項: (2022-04-01)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
著者:: Apichard Sukonthasarn, 等
出版事項: (2021-03-01)

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
著者:: Sheppard, J, 等
出版事項: (2014)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
著者:: Lopez-Lopez JP, 等
出版事項: (2023-09-01)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
著者:: Gunaratne Padma S, 等
出版事項: (2011-01-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
著者:: Samaneh Noroozi, 等
出版事項: (2021-04-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
著者:: Massimo F. Piepoli
出版事項: (2005-06-01)

The polypill: the solution for prevention of coronary heart disease?
著者:: Hendarto Natadidjaja
出版事項: (2016-02-01)

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
著者:: Sheppard, J, 等
出版事項: (2012)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
著者:: Николай Владимирович Абрамов, 等
出版事項: (2024-02-01)

Role of aspirin in primary prevention of cardiovascular disease
著者:: Patrono, C, 等
出版事項: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
著者:: VanWormer JJ, 等
出版事項: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
著者:: Ying Xing, 等
出版事項: (2019-07-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
著者:: Ramin Ravangard, 等
出版事項: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
著者:: Lilian Grigorian-Shamagian, 等
出版事項: (2021-08-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for primary for cardiovascular disease prevention
著者:: Sheppard, J, 等
出版事項: (2013)

The use of polypills in cardiovascular disease management: Benefits vs challenges
著者:: Yamaan Adil, 等
出版事項: (2024-09-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
著者:: Reza Jahangiri, 等
出版事項: (2022-01-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
著者:: Hennekens, C, 等
出版事項: (1989)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
著者:: Gautam Satheesh, 等
出版事項: (2024-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
著者:: Yinong Chen, 等
出版事項: (2021-09-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
著者:: Siddharth Birla, 等
出版事項: (2023-09-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
著者:: Lozano R, 等
出版事項: (2015-07-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
著者:: Sergio Coccheri
出版事項: (2017-04-01)

Aspirin for prevention of cancer and cardiovascular disease.
著者:: Rose, P, 等
出版事項: (2011)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
著者:: Gautam Satheesh, 等
出版事項: (2024-08-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
著者:: Eleni Giannopoulou, 等
出版事項: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
著者:: Athena L. Huang, 等
出版事項: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
著者:: Athena L. Huang, MD, 等
出版事項: (2023-09-01)

Preventing the progression of climate change: one drug or polypill?
著者:: Hugh Montgomery
出版事項: (2017-03-01)

Maybe it's time for something a little different? The extent to which current pharmacotherapy practice conforms to national guidelines for stroke and cardiovascular disease prevention
著者:: Sheppard, J, 等
出版事項: (2013)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
著者:: Price, H, 等
出版事項: (2009)

Polypill holds promise for people with chronic disease
著者:: Jacqui Wise
出版事項: (2005-12-01)

Aspirin in the primary prevention of vascular disease Reply
著者:: Baigent, C, 等
出版事項: (2009)